Diclofenac → 4-Isothiocyanatophenyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate

HRID 44170

반응식

HRID 44170 반응식
[CH:1]1[CH:2]=[CH:3][C:4]([NH:11][C:12]2[C:13]([Cl:19])=[CH:14][CH:15]=[CH:16][C:17]=2[Cl:18])=[C:5]([CH2:7][C:8]([OH:10])=[O:9])[CH:6]=1.O[C:21]1[C:29]2N=N[NH:26][C:25]=2[CH:24]=[CH:23][CH:22]=1.C1CCC(N=C=NC2CCCCC2)CC1.OC1C=CC(C2S[S:55][C:54](=S)C=2)=CC=1>CN(C)C=O.C(OCC)(=O)C>[Cl:19][C:13]1[CH:14]=[CH:15][CH:16]=[C:17]([Cl:18])[C:12]=1[NH:11][C:4]1[CH:3]=[CH:2][CH:1]=[CH:6][C:5]=1[CH2:7][C:8]([O:10][C:22]1[CH:23]=[CH:24][C:25]([N:26]=[C:54]=[S:55])=[CH:29][CH:21]=1)=[O:9]

참가 물질

7

반응 조건

온도
0 °C

실험 절차

To the solution of 1 (diclofenac, 1717 mg, 5.8 mmol) in 60 mL of dimethylformamide, hydroxybenzotriazole (862 mg, 6.38 mmol) and DCC (1316 mg, 6.38 mmol) were added with stirring at 0° C. for 1 h. To the reaction mixture 4-hydroxyphenylisothiocyanate (2; 965 mg, 6.38 mmol) was added and stirred for 1 h at 0° C. and 2 h at room temperature. After filtration, the filtrate was evaporated under reduced pressure to remove the solvent. The oily residue thus obtained was dissolved in ethyl acetate and the precipitate was removed. The solvent was evaporated and the crude product was loaded on a silica gel open column and eluted with chloroform/n-hexane 9:1, from which 4-isothiocyanatophenyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate (3) was obtained (580 mg, 23% yield).

후처리

  1. stirringstirred for 1 h at 0° C. and 2 h at room temperature
  2. filtrationAfter filtration
  3. customthe filtrate was evaporated under reduced pressure
  4. customto remove the solvent
  5. customThe oily residue thus obtained
  6. customthe precipitate was removed
  7. customThe solvent was evaporated
  8. washeluted with chloroform/n-hexane 9:1, from which 4-isothiocyanatophenyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate (3)
  9. customwas obtained (580 mg, 23% yield)

출처 및 근거

ORD 기록
ord-206a10ec26d64b0c904bc790354ed986
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08541398B2

연결된 노트

불러오는 중…